Whittier Trust’s Charles River Laboratories CRL Stock Holding History

Whittier Trust’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.3K	Hold	170	–	–	﹤0.01%	907
2026 Q1	$28.6K	Sell	170 -18	-10%	-$3.34K	﹤0.01%	937
2025 Q4	$40.6K	Hold	188	–	–	﹤0.01%	910
2025 Q3	$33.3K	Sell	188 -96	-34%	-$15.2K	﹤0.01%	929
2025 Q2	$43.1K	Buy	284 +20	+8%	+$2.67K	﹤0.01%	967
2025 Q1	$39.7K	Hold	264	–	–	﹤0.01%	976
2024 Q4	$48.7K	Sell	264 -144	-35%	-$27.7K	﹤0.01%	944
2024 Q3	$80.4K	Buy	408 +38	+10%	+$7.9K	﹤0.01%	839
2024 Q2	$76.4K	Hold	370	–	–	﹤0.01%	834
2024 Q1	$100K	Sell	370 -31	-8%	-$7.4K	﹤0.01%	784
2023 Q4	$94.8K	Sell	401 -396	-50%	-$77.9K	﹤0.01%	779
2023 Q3	$156K	Buy	797 +29	+4%	+$5.95K	﹤0.01%	673
2023 Q2	$161K	Sell	768 -70	-8%	-$13.9K	﹤0.01%	674
2023 Q1	$169K	Sell	838 -62	-7%	-$14.1K	﹤0.01%	693
2022 Q4	$196K	Sell	900 -15,391	-94%	-$3.36M	﹤0.01%	648
2022 Q3	$3.21M	Buy	16,291 +615	+4%	+$133K	0.07%	215
2022 Q2	$3.35M	Buy	15,676 +302	+2%	+$73.8K	0.07%	221
2022 Q1	$4.37M	Buy	15,374 +1,128	+8%	+$348K	0.07%	205
2021 Q4	$5.37M	Buy	14,246 +506	+4%	+$197K	0.09%	192
2021 Q3	$5.67M	Buy	13,740 +85	+0.6%	+$35.3K	0.1%	179
2021 Q2	$5.05M	Buy	13,655 +828	+6%	+$276K	0.09%	189
2021 Q1	$3.72M	Sell	12,827 -10,429	-45%	-$2.9M	0.07%	207
2020 Q4	$5.81M	Buy	23,256 +12,421	+115%	+$2.96M	0.12%	154
2020 Q3	$2.45M	Buy	+10,835	New	+$2.25M	0.06%	218
2020 Q1	–	Sell	-1,220	Closed	-$186K	–	1486
2019 Q4	$186K	Buy	1,220 +70	+6%	+$9.69K	﹤0.01%	571
2019 Q3	$152K	Hold	1,150	–	–	﹤0.01%	596
2019 Q2	$163K	Hold	1,150	–	–	﹤0.01%	567
2019 Q1	$167K	Hold	1,150	–	–	0.01%	560
2018 Q4	$130K	Hold	1,150	–	–	﹤0.01%	585
2018 Q3	$155K	Hold	1,150	–	–	﹤0.01%	555
2018 Q2	$129K	Hold	1,150	–	–	﹤0.01%	581
2018 Q1	$123K	Hold	1,150	–	–	﹤0.01%	601
2017 Q4	$126K	Hold	1,150	–	–	﹤0.01%	581
2017 Q3	$124K	Hold	1,150	–	–	﹤0.01%	567
2017 Q2	$116K	Hold	1,150	–	–	﹤0.01%	552
2017 Q1	$103K	Hold	1,150	–	–	﹤0.01%	577
2016 Q4	$88K	Hold	1,150	–	–	﹤0.01%	609
2016 Q3	$96K	Hold	1,150	–	–	﹤0.01%	582
2016 Q2	$95K	Hold	1,150	–	–	﹤0.01%	596
2016 Q1	$87K	Hold	1,150	–	–	﹤0.01%	610
2015 Q4	$92K	Hold	1,150	–	–	﹤0.01%	612
2015 Q3	$73K	Hold	1,150	–	–	﹤0.01%	639
2015 Q2	$81K	Hold	1,150	–	–	﹤0.01%	638
2015 Q1	$91K	Hold	1,150	–	–	﹤0.01%	609
2014 Q4	$73K	Hold	1,150	–	–	﹤0.01%	602
2014 Q3	$69K	Hold	1,150	–	–	﹤0.01%	605
2014 Q2	$62K	Hold	1,150	–	–	﹤0.01%	625
2014 Q1	$69K	Hold	1,150	–	–	﹤0.01%	610
2013 Q4	$61K	Hold	1,150	–	–	﹤0.01%	631
2013 Q3	$53K	Hold	1,150	–	–	﹤0.01%	659
2013 Q2	$47K	Buy	+1,150	New	+$49.3K	﹤0.01%	670

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Whittier Trust's CRL Position: Q2 2026 in Review

Whittier Trust held its Charles River Laboratories (CRL) position steady in Q2 2026 at 170 shares worth $39.3K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Whittier Trust first reported a position in CRL in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.81M in Q4 2020. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Whittier Trust held 170 shares of Charles River Laboratories worth $39.3K as of Q2 2026.
Whittier Trust left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #907 holding.
Whittier Trust first reported a position in Charles River Laboratories in Q2 2013 and has held it in 51 quarters since.
Whittier Trust's Charles River Laboratories position peaked at $5.81M in Q4 2020.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.